• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL CHROMAGAR ORIENTATION AND BBL TRYPTICASE SOY AGAR; CULTURE MEDIA, NON-SELECTIVE AND DIFFERENTIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL CHROMAGAR ORIENTATION AND BBL TRYPTICASE SOY AGAR; CULTURE MEDIA, NON-SELECTIVE AND DIFFERENTIAL Back to Search Results
Model Number 222239
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/19/2021
Event Type  malfunction  
Manufacturer Narrative
A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that while using bd bbl¿ chromagar¿ orientation and bbl¿ trypticase¿ soy agar foreign matter was observed by the laboratory personnel.There was no indication that results were reported out and there was no report of patient impact.
 
Event Description
It was reported that while using bd bbl¿ chromagar¿ orientation and bbl¿ trypticase¿ soy agar foreign matter was observed by the laboratory personnel.There was no indication that results were reported out and there was no report of patient impact.
 
Manufacturer Narrative
Investigation: during manufacturing of material 222239, media is formulated and sent through a high temperature short time sterilizer to remove bioburden.The petri dishes are subjected to uv radiation to decrease bioburden.The petri dishes are filled in a positive pressure hepa filtered environment.The filled plates are cooled and immediately wrapped into sleeves to decrease the introduction of microbes.Sleeves are then packaged into cartons and then transferred to a refrigerated truck (2 to 8 degrees c) for shipment to the distributor.Bd distributors are provided with the storage guidelines for the shipping and handling of bd media of 2 to 8 degrees c in a dark place.The batch history records for batches 0044951 and 0324225 were satisfactory at time of release.The release testing that is performed on this product does include bioburden testing.A sample of plates are incubated at 25 degrees c and at 35 degrees c for approximately 72 hours.All bioburden testing performed on this batch was satisfactory per bd internal procedures.Affected product does not have any sterility claims; the product is.Tested for bioburden prior to release to ensure that it conforms to product specifications.However, this does not ensure that the end-user will not receive a contaminated plate.The complaint history was reviewed, and the only other complaints taken on either batches 0044951 or 0324225 were also taken from this customer for contamination and other defects.Retention samples from batches 0044951 and 0324225 were not available for inspection.One photo was received for investigation.The photo shows the bottom of four taped plates from batch 0324225 (time stamps 2055, 2114, 2117 and 2204) with one microbial colony visible on the chromagar orientation medium of each plate.No return samples were received for this complaint.It is noted that batch 0044951 expired on 2020-05-13 and this complaint was taken on january 27, 2021.Bd makes no claims on expired products.However, previous complaints for contamination taken from this customer were before product expiration and were confirmed for contamination.This complaint can be confirmed for contamination for both batches in question.Bd will continue to trend complaints for contamination.Due to the number of complaints taken for contamination for material 222239, capa#3076308 has been initiated to determine the root cause and corrective actions of the contamination.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL CHROMAGAR ORIENTATION AND BBL TRYPTICASE SOY AGAR
Type of Device
CULTURE MEDIA, NON-SELECTIVE AND DIFFERENTIAL
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
MDR Report Key11363306
MDR Text Key241153017
Report Number1119779-2021-00348
Device Sequence Number1
Product Code JSH
UDI-Device Identifier10382902222399
UDI-Public10382902222399
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 09/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/22/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date02/22/2021
Device Model Number222239
Device Catalogue Number222239
Device Lot Number0324225
Was Device Available for Evaluation? No
Date Manufacturer Received09/04/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-